NA Medical Device Testing Market - Industry Trends and Forecast to 2029

Description

List of Tables

North America medical device testing market is projected to register a substantial CAGR of 11.3% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.

Market Segmentation:

North America Medical Device Testing Market, By Service Type (Testing Services, Inspection Service and Certification Services), Testing Type (Physical Testing, Chemical/Biological Testing, Cybersecurity Testing, Microbiology and Sterility Testing, and Others), Phase (Preclinical and Clinical), Sourcing Type (In-House and Outsourced), Device Class (Class I, Class II, and Class III), Product (Active Implant Medical Device, Active Medical Device, Non-active Medical Device, In-vitro Diagnostics Medical Device, Ophthalmic Medical Device, Orthopedic and Dental Medical Device, Vascular Medical Device, and Others) Country (U.S., Canada, and Mexico) Industry Trends and Forecast to 2029

Increasing demand for in-vitro tests

Market Players:

The key market players for North America medical device testing market are listed below:

Intertek Group plc

SGS SA

Bureau Veritas

TUV SUD

TUV Rheinland

Pace

Charles River Laboratories

Biomedical Device Labs

UL LLC

North American Science Associates, LLC

WuXi AppTec

NSF

Labcorp

Eurofins Scientific

Nelson Laboratories, LLC- A Sotera Health company

Gateway Analytical

Element Materials Technology

Medical Engineering Technologies Ltd.

Cigniti

Q Laboratories

IMR Test Labs

1 INTRODUCTION 28

1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.3 OVERVIEW OF NORTH AMERICA MEDICAL DEVICE TESTING MARKET 28
1.4 LIMITATIONS 30
1.5 MARKETS COVERED 30

2 MARKET SEGMENTATION 33

2.1 MARKETS COVERED 33
2.2 GEOGRAPHICAL SCOPE 34
2.3 YEARS CONSIDERED FOR THE STUDY 35
2.4 CURRENCY AND PRICING 35
2.5 DBMR TRIPOD DATA VALIDATION MODEL 36
2.6 MULTIVARIATE MODELLING 39
2.7 SERVICE TYPE LIFELINE CURVE 39
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 40
2.9 DBMR MARKET POSITION GRID 41
2.10 MARKET TESTING TYPE COVERAGE GRID 42
2.11 VENDOR SHARE ANALYSIS 43
2.12 SECONDARY SOURCES 44
2.13 ASSUMPTIONS 44

3 EXECUTIVE SUMMARY 45

4 PREMIUM INSIGHTS 48

4.1 PESTEL ANALYSIS 50
4.2 PORTER'S FIVE FORCES 51

5 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: REGULATIONS 52

6 MARKET OVERVIEW 56

6.1 DRIVERS 58
- 6.1.1 RISING NEED FOR VERIFICATION VALIDATION OF MEDICAL DEVICES 58
- 6.1.2 INCREASING DEMAND FOR IN-VITRO TESTS 58
- 6.1.3 ESCALATION IN INNOVATION AND TECHNOLOGIES 58
6.2 RESTRAINTS 59
- 6.2.1 BARRIERS TO THE LOCAL DEVELOPMENT OF MEDICAL DEVICES 59
- 6.2.2 HIGH COST OF MEDICAL DEVICES 59

6.3 OPPORTUNITIES 59
- 6.3.1 RISE IN HEALTHCARE EXPENDITURE 59
- 6.3.2 DEVELOPMENT IN AI AND IOT IN VARIOUS MEDICAL DEVICES 60
- 6.3.3 STRATEGIC INITIATIVES OF KEY PLAYERS 60
6.4 CHALLENGES 61
- 6.4.1 HIGH COMPETITION IN MEDICAL TECHNOLOGY INDUSTRY 61
- 6.4.2 LONG LEAD TIME FOR OVERSEAS QUALIFICATION 62

7 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE 63

7.1 OVERVIEW 64
7.2 TESTING SERVICES 67
7.3 INSPECTION SERVICES 67
7.4 CERTIFICATION SERVICES 68

8 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE 70

8.1 OVERVIEW 71
8.2 CHEMICAL/BIOLOGICAL TESTING 74
8.3 MICROBIOLOGY AND STERILITY TESTING 74
- 8.3.1 STERILITY TEST & VALIDATION 76
- 8.3.2 BIO BURDEN DETERMINATION 76
- 8.3.3 ANTIMICROBIAL ACTIVITY TESTING 76
- 8.3.4 PYROGEN & ENDOTOXIN TESTING 76
- 8.3.5 OTHERS 76
8.4 PHYSICAL TESTING 76
- 8.4.1 ELECTRICAL SAFETY TESTING 77
- 8.4.2 FUNCTIONAL SAFETY TESTING 78
- 8.4.3 EMC TESTING 78
- 8.4.4 ENVIRONMENTAL TESTING 78
- 8.4.5 OTHERS 78
8.5 CYBERSECURITY TESTING 78
8.6 OTHERS 79

9 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY PHASE 81

9.1 OVERVIEW 82
9.2 PRECLINICAL 85
9.3 CLINICAL 85

10 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE 87

10.1 OVERVIEW 88
10.2 OUTSOURCED 91
10.3 IN-HOUSE 91

11 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS 93

11.1 OVERVIEW 94
11.2 CLASS I 97
11.3 CLASS III 98
11.4 CLASS II 98

12 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY PRODUCT 100

12.1 OVERVIEW 101
12.2 NON-ACTIVE MEDICAL DEVICE 103
12.3 ORTHOPEDIC AND DENTAL MEDICAL DEVICE 104
12.4 ACTIVE IMPLANT MEDICAL DEVICE 105
12.5 VASCULAR MEDICAL DEVICE 106
12.6 ACTIVE MEDICAL DEVICE 107
12.7 IN-VITRO DIAGNOSTICS MEDICAL DEVICE 107
12.8 OPTHALMIC MEDICAL DEVICE 108
12.9 OTHERS 109

13 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY GEOGRAPHY 110

13.1 NORTH AMERICA 111
- 13.1.1 U.S. 118
- 13.1.2 CANADA 121
- 13.1.3 MEXICO 124

14 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: COMPANY LANDSCAPE 127

14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 127

15 SWOT ANALYSIS 128

16 COMPANY PROFILE 129

16.1 LABCORP 129
- 16.1.1 COMPANY SNAPSHOT 129
- 16.1.2 REVENUE ANALYSIS 129
- 16.1.3 COMPANY SHARE ANALYSIS 130
- 16.1.4 PRODUCT PORTFOLIO 130
- 16.1.5 RECENT DEVELOPMENTS 130
16.2 CHARLES RIVER LABORATORIES. 131
- 16.2.1 COMPANY SNAPSHOT 131
- 16.2.2 REVENUE ANALYSIS 131
- 16.2.3 COMPANY SHARE ANALYSIS 132
- 16.2.4 PRODUCT PORTFOLIO 132
- 16.2.5 RECENT DEVELOPMENTS 132

16.3 TUV SUD 133
- 16.3.1 COMPANY SNAPSHOT 133
- 16.3.2 REVENUE ANALYSIS 133
- 16.3.3 COMPANY SHARE ANALYSIS 134
- 16.3.4 PRODUCT PORTFOLIO 134
- 16.3.5 RECENT DEVELOPMENTS 135
16.4 WUXI APPTEC 136
- 16.4.1 COMPANY SNAPSHOT 136
- 16.4.2 REVENUE ANALYSIS 136
- 16.4.3 COMPANY SHARE ANALYSIS 137
- 16.4.4 PRODUCT PORTFOLIO 137
- 16.4.5 RECENT DEVELOPMENTS 138
16.5 SGS SA 139
- 16.5.1 COMPANY SNAPSHOT 139
- 16.5.2 REVENUE ANALYSIS 139
- 16.5.3 COMPANY SHARE ANALYSIS 140
- 16.5.4 PRODUCT PORTFOLIO 140
- 16.5.5 RECENT DEVELOPMENTS 141
16.6 NORTH AMERICAN SCIENCE ASSOCIATES, LLC 142
- 16.6.1 COMPANY SNAPSHOT 142
- 16.6.2 PRODUCT PORTFOLIO 142
- 16.6.3 RECENT DEVELOPMENTS 142
16.7 HOHENSTEIN 143
- 16.7.1 COMPANY SNAPSHOT 143
- 16.7.2 PRODUCT PORTFOLIO 143
- 16.7.3 RECENT DEVELOPMENTS 143
16.8 ARBRO PHARMACEUTICALS PRIVATE LIMITED & AURIGA RESEARCH PRIVATE LIMITED 144
- 16.8.1 COMPANY SNAPSHOT 144
- 16.8.2 PRODUCT PORTFOLIO 144
- 16.8.3 RECENT DEVELOPMENTS 144
16.9 BIOMEDICAL DEVICE LABS 145
- 16.9.1 COMPANY SNAPSHOT 145
- 16.9.2 PRODUCT PORTFOLIO 145
- 16.9.3 RECENT DEVELOPMENTS 145
16.10 BIONEEDS 146
- 16.10.1 COMPANY SNAPSHOT 146
- 16.10.2 PRODUCT PORTFOLIO 146
- 16.10.3 RECENT DEVELOPMENTS 146

16.11 BUREAU VERITAS 147
- 16.11.1 COMPANY SNAPSHOT 147
- 16.11.2 REVENUE ANALYSIS 147
- 16.11.3 PRODUCT PORTFOLIO 148
- 16.11.4 RECENT DEVELOPMENTS 148
16.12 CIGNITI 149
- 16.12.1 COMPANY SNAPSHOT 149
- 16.12.2 REVENUE ANALYSIS 149
- 16.12.3 PRODUCT PORTFOLIO 150
- 16.12.4 RECENT DEVELOPMENTS 150
16.13 ELEMENT MATERIALS TECHNOLOGY 151
- 16.13.1 COMPANY SNAPSHOT 151
- 16.13.2 PRODUCT PORTFOLIO 151
- 16.13.3 RECENT DEVELOPMENTS 151
16.14 ENDOLAB MECHANICAL ENGINEERING GMBH 152
- 16.14.1 COMPANY SNAPSHOT 152
- 16.14.2 PRODUCT PORTFOLIO 152
- 16.14.3 RECENT DEVELOPMENTS 152
16.15 EUROFINS SCIENTIFIC 153
- 16.15.1 COMPANY SNAPSHOT 153
- 16.15.2 REVENUE ANALYSIS 153
- 16.15.3 PRODUCT PORTFOLIO 154
- 16.15.4 RECENT DEVELOPMENTS 154
16.16 GATEWAY ANALYTICAL. 155
- 16.16.1 COMPANY SNAPSHOT 155
- 16.16.2 PRODUCT PORTFOLIO 155
- 16.16.3 RECENT DEVELOPMENTS 155
16.17 IMR TEST LABS 156
- 16.17.1 COMPANY SNAPSHOT 156
- 16.17.2 PRODUCT PORTFOLIO 156
- 16.17.3 RECENT DEVELOPMENTS 156
16.18 INTERTEK GROUP PLC 157
- 16.18.1 COMPANY SNAPSHOT 157
- 16.18.2 REVENUE ANALYSIS 157
- 16.18.3 PRODUCT PORTFOLIO 158
- 16.18.4 RECENT DEVELOPMENTS 158
16.19 ITC ZLIN 159
- 16.19.1 COMPANY SNAPSHOT 159
- 16.19.2 PRODUCT PORTFOLIO 159
- 16.19.3 RECENT DEVELOPMENTS 159
16.20 MEDICAL ENGINEERING TECHNOLOGIES LTD. 160
- 16.20.1 COMPANY SNAPSHOT 160
- 16.20.2 PRODUCT PORTFOLIO 160
- 16.20.3 RECENT DEVELOPMENTS 160
16.21 MEDISTRI SA 161
- 16.21.1 COMPANY SNAPSHOT 161
- 16.21.2 PRODUCT PORTFOLIO 161
- 16.21.3 RECENT DEVELOPMENTS 161
16.22 NELSON LABORATORIES, LLC- A SOTERA HEALTH COMPANY 162
- 16.22.1 COMPANY SNAPSHOT 162
- 16.22.2 REVENUE ANALYSIS 162
- 16.22.3 PRODUCT PORTFOLIO 163
- 16.22.4 RECENT DEVELOPMENTS 163
16.23 NSF. 164
- 16.23.1 COMPANY SNAPSHOT 164
- 16.23.2 PRODUCT PORTFOLIO 164
- 16.23.3 RECENT DEVELOPMENTS 164
16.24 PACE 165
- 16.24.1 COMPANY SNAPSHOT 165
- 16.24.2 PRODUCT PORTFOLIO 165
- 16.24.3 RECENT DEVELOPMENTS 165
16.25 Q LABORATORIES 166
- 16.25.1 COMPANY SNAPSHOT 166
- 16.25.2 PRODUCT PORTFOLIO 166
- 16.25.3 RECENT DEVELOPMENTS 166
16.26 TUV RHEINLAND 167
- 16.26.1 COMPANY SNAPSHOT 167
- 16.26.2 REVENUE ANALYSIS 167
- 16.26.3 PRODUCT PORTFOLIO 168
- 16.26.4 RECENT DEVELOPMENTS 168
16.27 UL LLC 169
- 16.27.1 COMPANY SNAPSHOT 169
- 16.27.2 PRODUCT PORTFOLIO 169
- 16.27.3 RECENT DEVELOPMENTS 170

17 QUESTIONNAIRE 171

18 RELATED REPORTS 174

LIST OF TABLES

TABLE 1 FDA REGULATIONS BASED ON DEVICES TYPE 41
TABLE 2 PRICES OF ESSENTIAL MEDICAL DEVICES 47
TABLE 3 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE, 2020-2029 (USD MILLION) 54
TABLE 4 NORTH AMERICA TESTING SERVICES IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 55
TABLE 5 NORTH AMERICA INSPECTION SERVICES IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 56
TABLE 6 NORTH AMERICA CERTIFICATION SERVICES IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 57
TABLE 7 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2020-2029 (USD MILLION) 61
TABLE 8 NORTH AMERICA CHEMICAL/BIOLOGICAL TESTING IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 62
TABLE 9 NORTH AMERICA MICROBIOLOGY AND STERILITY TESTING IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 63
TABLE 10 NORTH AMERICA MICROBIOLOGY AND STERILITY TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2020-2029 (USD MILLION) 64
TABLE 11 NORTH AMERICA PHYSICAL TESTING IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 65
TABLE 12 NORTH AMERICA PHYSICAL TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2020-2029 (USD MILLION) 65
TABLE 13 NORTH AMERICA CYBERSECURITY TESTING IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 67
TABLE 14 NORTH AMERICA OTHERS IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 68
TABLE 15 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY PHASE, 2020-2029 (USD MILLION) 72
TABLE 16 NORTH AMERICA PRECLINICAL IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 73
TABLE 17 NORTH AMERICA CLINICAL IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 74
TABLE 18 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE, 2020-2029 (USD MILLION) 78
TABLE 19 NORTH AMERICA OUTSOURCED IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 79
TABLE 20 NORTH AMERICA IN-HOUSE IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 80
TABLE 21 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS, 2020-2029 (USD MILLION) 84
TABLE 22 NORTH AMERICA CLASS I IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 85
TABLE 23 NORTH AMERICA CLASS III IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 86
TABLE 24 NORTH AMERICA CLASS II IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 87
TABLE 25 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 91
TABLE 26 NORTH AMERICA NON-ACTIVE MEDICAL DEVICE IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 92
TABLE 27 NORTH AMERICA ORTHOPEDIC AND DENTAL MEDICAL DEVICE IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 93
TABLE 28 NORTH AMERICA ACTIVE IMPLANT MEDICAL DEVICE IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 94
TABLE 29 NORTH AMERICA VASCULAR MEDICAL DEVICE IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 94
TABLE 30 NORTH AMERICA ACTIVE MEDICAL DEVICE IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 95
TABLE 31 NORTH AMERICA IN-VITRO MEDICAL DEVICE IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 96
TABLE 32 NORTH AMERICA OPTHALMIC MEDICAL DEVICE IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 97
TABLE 33 NORTH AMERICA OTHERS IN MEDICAL DEVICE TESTING MARKET, BY REGION, 2020-2029 (USD MILLION) 97
TABLE 34 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 103
TABLE 35 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE, 2020-2029 (USD MILLION) 103
TABLE 36 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2020-2029 (USD MILLION) 103
TABLE 37 NORTH AMERICA MICROBIOLOGY AND STERILITY TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2020-2029 (USD MILLION) 103
TABLE 38 NORTH AMERICA PHYSICAL TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2020-2029 (USD MILLION) 104
TABLE 39 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY PHASE, 2020-2029 (USD MILLION) 104
TABLE 40 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE, 2020-2029 (USD MILLION) 104
TABLE 41 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS, 2020-2029 (USD MILLION) 104
TABLE 42 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 105
TABLE 43 U.S. MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE, 2020-2029 (USD MILLION) 106
TABLE 44 U.S. MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2020-2029 (USD MILLION) 106
TABLE 45 U.S. MICROBIOLOGY AND STERILITY TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2020-2029 (USD MILLION) 106
TABLE 46 U.S. PHYSICAL TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2020-2029 (USD MILLION) 107
TABLE 47 U.S. MEDICAL DEVICE TESTING MARKET, BY PHASE, 2020-2029 (USD MILLION) 107
TABLE 48 U.S. MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE, 2020-2029 (USD MILLION) 107
TABLE 49 U.S. MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS, 2020-2029 (USD MILLION) 107
TABLE 50 U.S. MEDICAL DEVICE TESTING MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 108
TABLE 51 CANADA MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE, 2020-2029 (USD MILLION) 109
TABLE 52 CANADA MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2020-2029 (USD MILLION) 109
TABLE 53 CANADA MICROBIOLOGY AND STERILITY TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2020-2029 (USD MILLION) 109
TABLE 54 CANADA PHYSICAL TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2020-2029 (USD MILLION) 110
TABLE 55 CANADA MEDICAL DEVICE TESTING MARKET, BY PHASE, 2020-2029 (USD MILLION) 110
TABLE 56 CANADA MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE, 2020-2029 (USD MILLION) 110
TABLE 57 CANADA MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS, 2020-2029 (USD MILLION) 110
TABLE 58 CANADA MEDICAL DEVICE TESTING MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 111
TABLE 59 MEXICO MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE, 2020-2029 (USD MILLION) 112
TABLE 60 MEXICO MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2020-2029 (USD MILLION) 112
TABLE 61 MEXICO MICROBIOLOGY AND STERILITY TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2020-2029 (USD MILLION) 112
TABLE 62 MEXICO PHYSICAL TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2020-2029 (USD MILLION) 113
TABLE 63 MEXICO MEDICAL DEVICE TESTING MARKET, BY PHASE, 2020-2029 (USD MILLION) 113
TABLE 64 MEXICO MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE, 2020-2029 (USD MILLION) 113
TABLE 65 MEXICO MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS, 2020-2029 (USD MILLION) 113
TABLE 66 MEXICO MEDICAL DEVICE TESTING MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 114

LIST OF FIGURES

FIGURE 1 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: SEGMENTATION 20
FIGURE 2 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: DATA TRIANGULATION 23
FIGURE 3 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: DROC ANALYSIS 24
FIGURE 4 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS 25
FIGURE 5 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: COMPANY RESEARCH ANALYSIS 25
FIGURE 6 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: INTERVIEW DEMOGRAPHICS 27
FIGURE 7 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: DBMR MARKET POSITION GRID 28
FIGURE 8 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: MARKET TESTING TYPE COVERAGE GRID 29
FIGURE 9 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: VENDOR SHARE ANALYSIS 30
FIGURE 10 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: SEGMENTATION 34
FIGURE 11 INCREASING DEMAND FOR IN-VITRO TESTS AND DEVELOPMENT IN AI AND IOT IN VARIOUS MEDICAL DEVICES ARE EXPECTED TO DRIVE THE NORTH AMERICA MEDICAL DEVICE TESTING MARKET IN THE FORECAST PERIOD OF 2022 TO 2029 35
FIGURE 12 TESTING SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA MEDICAL DEVICE TESTING MARKET IN 2022 & 2029 35
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA MEDICAL DEVICE TESTINGMARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029 36
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA MEDICAL DEVICE TESTING MARKET 44
FIGURE 15 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE, 2021 51
FIGURE 16 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE, 2022-2029 (USD MILLION) 52
FIGURE 17 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE, CAGR (2022-2029) 52
FIGURE 18 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE, LIFELINE CURVE 53
FIGURE 19 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY TESTING TYPE, 2021 58
FIGURE 20 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY TESTING TYPE, 2022-2029 (USD MILLION) 59
FIGURE 21 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY TESTING TYPE, CAGR (2022-2029) 59
FIGURE 22 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY TESTING TYPE, LIFELINE CURVE 60
FIGURE 23 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PHASE, 2021 69
FIGURE 24 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PHASE, 2022-2029 (USD MILLION) 70
FIGURE 25 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PHASE, CAGR (2022-2029) 70
FIGURE 26 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PHASE, LIFELINE CURVE 71
FIGURE 27 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SOURCING TYPE, 2021 75
FIGURE 28 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SOURCING TYPE, 2022-2029 (USD MILLION) 76
FIGURE 29 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SOURCING TYPE, CAGR (2022-2029) 76
FIGURE 30 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SOURCING TYPE, LIFELINE CURVE 77
FIGURE 31 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY DEVICE CLASS, 2021 81
FIGURE 32 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY DEVICE CLASS, 2022-2029 (USD MILLION) 82
FIGURE 33 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY DEVICE CLASS, CAGR (2022-2029) 82
FIGURE 34 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY DEVICE CLASS, LIFELINE CURVE 83
FIGURE 35 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PRODUCT, 2021 88
FIGURE 36 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PRODUCT, 2022-2029 (USD MILLION) 89
FIGURE 37 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PRODUCT, CAGR (2022-2029) 89
FIGURE 38 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PRODUCT, LIFELINE CURVE 90
FIGURE 39 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: SNAPSHOT (2021) 99
FIGURE 40 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY COUNTRY (2021) 100
FIGURE 41 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY COUNTRY (2022 & 2029) 100
FIGURE 42 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY COUNTRY (2021 & 2029) 101
FIGURE 43 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE (2022-2029) 101
FIGURE 44 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: COMPANY SHARE 2021 (%) 114